Dr. Charlie Serhan, awarded the 2016 Ross Prize in Molecular Medicine

It gives me great pleasure to announce that Charles N. Serhan, PhD, is the recipient of the 2016 Ross Prize in Molecular Medicine. Dr. Serhan, of Brigham and Women's Hospital and Harvard Medical School, receives this award in recognition of his important discovery concerning the mechanistic basis for inflammation resolution and translation of that discovery to the clinic.

The annual Ross Prize in Molecular Medicine is issued via the Feinstein Institute's peer-reviewed, open-access journal, Molecular Medicine, and is awarded annually to scientists who have made a demonstrable impact in the understanding of human diseases pathogenesis and/or treatment, and who hold significant promise for making even greater contributions to the general field of molecular medicine.

Dr. Serhan will receive an award trophy and honorarium of $50,000 from Molecular Medicine, and present the keynote lecture at the Award Ceremony and Mini-Symposium on Monday, June 13, 2016, at the New York Academy of Sciences in Manhattan. To read more about the Ross Prize in Molecular Medicine, click here.

Dr. Serhan has received numerous distinguished lectureships and awards including the John Vane Lecture and William Harvey Outstanding Scientist Medal in 2008. He has published over 500 publications and 400 patents, and served as a mentor to over 40 trainees throughout his career.

On behalf of the Committee of the Ross Prize in Molecular Medicine and the Feinstein Institute, please join me in congratulating Dr. Serhan.


Christopher J. Czura, PhD Publisher Feinstein Institute Press Molecular Medicine & Bioelectronic Medicine